Mauch, L., A. Lun, M. R. G. O'Gorman, J. S. Harris, I. Schulze, A. Zychlinsky, T. Fuchs, U. Oelschlägel, S. Brenner, D. Kutter, A. Rösen-Wolff and J. Roesler: Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. In: Clinical Chemistry 53, 5, 890-896 (2007).
doi: 10.1373/clinchem.2006.083444
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.